Shanghai Pharmaceuticals Holding Co (SHSE:601607) Accounts Payable & Accrued Expense : ¥75,583 Mil (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Accounts Payable & Accrued Expense?

Shanghai Pharmaceuticals Holding Co's quarterly accounts payable & accrued expense declined from Jun. 2023 (¥78,746 Mil) to Sep. 2023 (¥77,266 Mil) and declined from Sep. 2023 (¥77,266 Mil) to Dec. 2023 (¥75,583 Mil).

Shanghai Pharmaceuticals Holding Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥58,184 Mil) to Dec. 2022 (¥71,062 Mil) and increased from Dec. 2022 (¥71,062 Mil) to Dec. 2023 (¥75,583 Mil).

Shanghai Pharmaceuticals Holding Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Accounts Payable & Accrued Expense Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

48,744.43

52,687.00

58,183.63

71,061.70

75,582.96

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															71,061.70	71,674.56	78,745.56	77,265.64	75,582.96

Shanghai Pharmaceuticals Holding Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines